v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 66,285,901 $ 40,650,770
Short-term investments 11,216,989 11,036,857
Trade receivables, net 54,611,147 51,653,583
Inventories 7,487,708 7,599,535
Prepaid research and development expenses 134,907 152,823
Other prepaid expenses and current assets 5,124,924 3,481,868
Total current assets 144,861,576 114,575,436
Property and equipment, net 1,728,199 1,828,016
Other assets 642,066
License intangible asset, net 1,792,208 1,844,156
Restricted cash, long-term 105,084 105,368
Operating lease right-of-use asset 453,633 492,697
TOTAL ASSETS 149,582,766 118,845,673
Current liabilities    
Accounts payable 1,933,136 1,720,177
Accrued expenses 32,284,995 31,951,533
Operating lease liability, short-term 172,495 167,922
Total current liabilities 34,390,626 33,839,632
Operating lease liability, net of current portion 304,092 349,091
TOTAL LIABILITIES 34,694,718 34,188,723
COMMITMENTS AND CONTINGENCIES (Note 5)
STOCKHOLDERS’ EQUITY    
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 91,623 and 136,623 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 92 137
Common stock - $0.001 par value: 160,000,000 shares authorized; 67,711,098 and 64,411,295 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 67,711 64,411
Accumulated other comprehensive gain 84,556 90,646
Additional paid-in capital 433,721,824 424,131,789
Accumulated deficit (318,986,135) (339,630,033)
TOTAL STOCKHOLDERS’ EQUITY 114,888,048 84,656,950
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 149,582,766 $ 118,845,673